Literature DB >> 28786838

Perioperative Considerations for the Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes.

Sharon C Peacock1, Julie A Lovshin2,3, David Z I Cherney3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 28786838     DOI： 10.1213/ANE.0000000000002377

Source DB:  PubMed          Journal:  Anesth Analg        ISSN： 0003-2999            Impact factor:   5.108


× No keyword cloud information.
  4 in total

1.  [Severe SGLT-2 inhibitor-induced euglycemic ketoacidosis-a rare but serious complication].

Authors:  E Rotsel; U Pietsch
Journal:  Anaesthesist       Date:  2019-12-05       Impact factor: 1.041

Review 2.  The New Biology of Diabetic Kidney Disease-Mechanisms and Therapeutic Implications.

Authors:  Yuliya Lytvyn; Petter Bjornstad; Daniel H van Raalte; Hiddo L Heerspink; David Z I Cherney
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

3.  Response by Lytvyn et al to Letter Regarding Article, "Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials".

Authors:  Yuliya Lytvyn; Petter Bjornstad; Jacob A Udell; Julie A Lovshin; David Z I Cherney
Journal:  Circulation       Date:  2018-05-01       Impact factor: 29.690

4.  Early Presentation of a Rare Complication of Sodium-Glucose Cotransporter-2 Inhibitors 10 Days After Initiation: Case Report and Literature Review.

Authors:  Ghada Elshimy; Ricardo Correa; Mahmoud Alsayed; Sathya Jyothinagaram
Journal:  Cureus       Date:  2019-07-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.